 |
|
|
|
|
|
|
| Article 1 to 10 out of 11 concerning MedMira Inc.
|
-
MedMira Awarded China Patent
(25 Jul 2008)
Rapid Flow-Through Technology Patents in Three Major Global Markets
MedMira Inc. announced that it received a Notice on Grant of Patent Right For Invention (equivalent to the Notice of Allowance in the United States) from the State Intellectual Property Office (SIPO) of the People's Republic of China for its rapid ...
-
US Patent for Rapid Test Method and Technology Platform Awarded to MedMira
(18 Jul 2008)
MedMira Inc. announced that it received a Notice of Allowance from the United States Patent and Trademark Office for its rapid flow-through test (RFT) methodology, the technology platform its rapid tests are built on.This patent protects the core ...
-
MedMira Files Patent Application for Next Generation Rapid Test
(19 Mar 2008)
MedMira Inc. announced that it has filed a patent application with the United States Patent Office for its new rapid test platform. MedMira's research & development team has been working on a next generation, rapid test based on the company's ...
-
MedMira Wins Government Tender in Russia
(10 Dec 2007)
MedMira Inc. announced that it has won an official government tender in the Republic of Tatarsan with its Multiplo(TM) Rapid HBV/HIV/HCV Antibody Test (Multiplo HBV/HIV/HCV). This success is the first in the Company's drive to penetrate the ...
-
MedMira's HIV Test Approved Under USAID Initiative
(20 Nov 2007)
Allows for International Purchase as Part of US Presidential Plan for AIDS Relief
MedMira Inc. announced that its Reveal G3 Rapid HIV-1 Antibody Test ("Reveal G3") has been approved for purchase by the U.S. Agency for International Development ("USAID"), resulting in the placement of Reveal G3 on USAID's rapid HIV test ...
-
MedMira's Biosensor Division to Receive $3 million from ACOA's Atlantic Innovation Fund
(19 Jan 2007)
Investment in Maple Biosciences Shall Support Development of Revolutionary Diagnostics
MedMira Inc. will receive up to $3 million from the Atlantic Canada Opportunities Agency (ACOA), under the Atlantic Innovation Fund. This financial contribution shall enable MedMira's biosensor division, Maple Biosciences, to undertake a $5.4 ...
-
MedMira Signs Italian Distributor for Rapid HIV Test
(27 Nov 2006)
MedMira Inc. announced that it has signed an exclusive distribution agreement with Italian distributor Voden Medical Instruments spa (Voden). Voden will distribute MedMira's MiraCare(TM) Rapid HIV Antibody Test (MiraCare HIV) to point-of-care and ...
-
MedMira Increases Global Sales Force to Capitalize on Product Approvals
(30 Jun 2006)
MedMira Inc. announced that it has expanded its global sales team in order to capitalize on market penetration opportunities from recently completed key regulatory approvals.The expansion includes two new regional account managers dedicated to the ...
-
MedMira Completes Acquisition of BAG-1 Technology
(31 May 2006)
MedMira Inc. announced that it has closed the transaction to acquire the BAG-1, an emerging cancer marker technology, that was announced on April 3, 2006. Under the terms of the acquisition agreement MedMira will acquire the BAG-1 technology for a ...
-
MedMira Completes Acquisition of SensorChem
(27 Feb 2006)
MedMira Inc. announced that it has closed the transaction to acquire SensorChem International Corp., that was announced on December 15, 2005.Under the terms of the acquisition agreement, MedMira has acquired all of the outstanding common shares of ...
|
|
|
|
|
Top
analytica
analytica China
analytica Vietnam
analytica Anacon